Zobrazeno 1 - 10
of 5 947
pro vyhledávání: '"myofibroblastic"'
Publikováno v:
Discover Oncology, Vol 15, Iss 1, Pp 1-7 (2024)
Abstract Epithelioid inflammatory myofibroblastic sarcoma (EIMS) is a rare subtype of inflammatory myofibroblastic tumor, characterized to be an aggressive disease with high frequency of ALK rearrangement, rapid recurrence, and poor prognosis. Primar
Externí odkaz:
https://doaj.org/article/81268a47bb3c4a13aac672d12b7e0003
Autor:
David Zezoff, DO, Stefanie Lowas, MD, Muriel Cleary, MD, Ali Akalin, MD, Farhana Riaz, MD, Jean-Marc Gauguet, MD/PhD
Publikováno v:
Radiology Case Reports, Vol 19, Iss 12, Pp 6199-6204 (2024)
Epithelioid inflammatory myofibroblastic sarcoma, a variant of the inflammatory myofibroblastic tumor, is a rare tumor that is not well described in the radiologic literature. We present a case of a 14-year-old male adolescent who presented with feve
Externí odkaz:
https://doaj.org/article/09b6bcfc3b154af497859eebc75f2b42
Publikováno v:
Precision Medical Sciences, Vol 13, Iss 3, Pp 167-171 (2024)
Abstract To explore computed tomography (CT) findings and pathological features of intestinal inflammatory myofibroblastic tumors (IMT). A retrospective review was conducted on the CT features of five patients with pathologically confirmed IMT, which
Externí odkaz:
https://doaj.org/article/9707aa49b4df46c3ae59afeef17a0e37
Publikováno v:
Journal of Pathology and Translational Medicine, Vol 58, Iss 3, Pp 141-145 (2024)
An aggressive subtype of inflammatory myofibroblastic tumor, epithelioid inflammatory myofibroblastic sarcoma occurs primarily inside the abdominal cavity, followed by a pulmonary localization. Most harbor anaplastic lymphoma kinase (ALK) gene rearra
Externí odkaz:
https://doaj.org/article/fbad169d6c6e429eb9ca1da6f26ca747
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Epithelioid inflammatory myofibroblastic sarcoma (EIMS) is an extremely rare and aggressive form of inflammatory myofibroblastic tumor. Clinically, it has a high risk of relapse and peripheral organ infiltration, and it responds poorly to conventiona
Externí odkaz:
https://doaj.org/article/b5c787c134bf4cb4892f4f95f39aef5e
Publikováno v:
Journal of Indian Association of Pediatric Surgeons, Vol 29, Iss 5, Pp 546-548 (2024)
Inflammatory myofibroblastic tumor (IMT) is a very rare tumor with still rare occurrence in the genitourinary system, presenting as a pelvic-ureteric junction (PUJ) obstruction (PUJO). We report a case of IMT at the PUJ mimicking congenital PUJO and
Externí odkaz:
https://doaj.org/article/293f686e19b94fb49b1cda22aeafbd43
Autor:
Johana Benedetti Pedroza, Irene Carrasco García, Gala Martínez Bernal, Isabel Miras Rodriguez
Publikováno v:
Case Reports in Oncology, Vol 17, Iss 1, Pp 763-772 (2024)
Introduction: Inflammatory myofibroblastic tumor (IMT) is a rare entity, classified within soft tissue sarcomas. It is an intermediate malignancy tumor, which seldom presents as metastatic disease. The treatment of choice is surgery, except in cases
Externí odkaz:
https://doaj.org/article/b4126599924348d9b506d42e44f7dab1
Autor:
Faiz Manzar Ansari, Sajad Ahmad Para, Mohammad Saleem Wani, Arif Hamid Bhat, Abdul Rouf Khawaja, Zafirah Zahir
Publikováno v:
African Journal of Urology, Vol 30, Iss 1, Pp 1-4 (2024)
Abstract Background Inflammatory myofibroblastic tumor (IMT) of urinary bladder is a rare entity of genitourinary tract which has baffled urologists worldwide. Sign and symptoms are site specific. Usually diagnosed on the basis of immunohistochemistr
Externí odkaz:
https://doaj.org/article/b3c3a827c7fc46c49ee1edbbea8f6691
Autor:
Eui Gyu Sin, Junguee Lee
Publikováno v:
Case Reports in Oncology, Vol 17, Iss 1, Pp 705-711 (2024)
Introduction: Inflammatory pseudotumor encompasses a broad range of non-neoplastic and neoplastic entities, including inflammatory myofibroblastic tumors (IMTs). Because it is a rare mesenchymal tumor of unknown etiology and pathogenesis, and its cli
Externí odkaz:
https://doaj.org/article/ec99fef65153413ebfc4ed8cf2ba92c7
Publikováno v:
Journal of Cancer Research and Practice, Vol 11, Iss 2, Pp 77-80 (2024)
Inflammatory myofibroblastic tumor (IMT) is an intermediate malignant neoplasm, and approximately 50% of patients are anaplastic lymphoma kinase positive (ALK+). Given this unique trait, ALK tyrosine kinase inhibitors (TKIs), initially developed for
Externí odkaz:
https://doaj.org/article/745795b0085b4962a4cabca721e9aef9